Difficulty: Medium
Average Score: 93%
Practice
A 45-year-old man with attention-deficit/hyperactivity disorder presents to his primary care physician for evaluation and treatment. Physical examination of the heart, lungs, and abdomen are within normal limits. The patient has begun on atomoxetine. Which of the following underlying disorders must the treating physician be aware of?
Correct answer
B
Rationale
In this case, the correct answer is B) Bipolar disease. Atomoxetine is a non-stimulant medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). It is important for the treating physician to be aware of the possibility of underlying bipolar disease in this patient because atomoxetine can potentially exacerbate manic symptoms in individuals with undiagnosed or untreated bipolar disorder.
Option A) Anxiety, Option C) Bleeding disorders, and Option D) Chronic diarrhea are not directly related to the choice of atomoxetine for ADHD treatment. While anxiety may be a comorbid condition with ADHD, it is not a specific concern related to atomoxetine use. Bleeding disorders and chronic diarrhea are also not typically associated with the use of atomoxetine.
Educationally, understanding the potential interactions and contraindications of CNS drugs like atomoxetine is crucial for healthcare providers. Recognizing the need to screen for underlying psychiatric conditions like bipolar disorder before initiating treatment can help prevent adverse reactions and ensure optimal patient care. This knowledge can enhance clinical decision-making and improve patient outcomes in pharmacological practice.
Option A) Anxiety, Option C) Bleeding disorders, and Option D) Chronic diarrhea are not directly related to the choice of atomoxetine for ADHD treatment. While anxiety may be a comorbid condition with ADHD, it is not a specific concern related to atomoxetine use. Bleeding disorders and chronic diarrhea are also not typically associated with the use of atomoxetine.
Educationally, understanding the potential interactions and contraindications of CNS drugs like atomoxetine is crucial for healthcare providers. Recognizing the need to screen for underlying psychiatric conditions like bipolar disorder before initiating treatment can help prevent adverse reactions and ensure optimal patient care. This knowledge can enhance clinical decision-making and improve patient outcomes in pharmacological practice.